Clinical Trials Directory

Trials / Completed

CompletedNCT04217239

A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

A Comparison of Short-term and Long- Term Outcomes Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
272 (actual)
Sponsor
The Second Hospital of Shandong University · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Surgery is still the main treatment for esophageal cancer, however, the complication and mortality rate of open esophagectomy is high. As a result, the thoracoscopic- laparoscopic minimally invasive esophagectomy (MIE) was developed. The MIE mainly comprised two surgical approaches: MIE McKeown approach (cervical anastomosis) and MIE Ivor-Lewis approach (intrathoracicanastomosis). The MIE with intrathoracic anastomosis (Ivor-Lewis) is increasingly used for the treatment of mid and lower esophageal cancers. Our study is trying to compare the safety, feasibility, and short-term and long- term outcomes between MIE Ivor-Lewis approach and MIE McKeown approach for the treatment of lower thoracic esophageal cancer and esophageal- gastric junction.

Conditions

Interventions

TypeNameDescription
PROCEDUREMIE Ivor- Lewisminimally invasive esophagectomy (MIE) with intrathoracic anastomosis
PROCEDUREMIE McKeownminimally invasive esophagectomy (MIE) with cervical anastomosis

Timeline

Start date
2020-01-01
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2020-01-03
Last updated
2026-02-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04217239. Inclusion in this directory is not an endorsement.